A Study Evaluating Safety and Efficacy of BIOD 531 Compared to Humalog® Mix 75/25 in Subjects With Type 2 Diabetes

To Investigate the Efficacy and Safety of Individualized Doses of BioChaperone Insulin Lispro in Comparison to Humalog® U-100 in Patients With Type 1 Diabetes Mellitus

NCT02528396 ·Status: COMPLETED ·Phase: PHASE1

Safety and Efficacy of Exenatide in Patients With Type 2 Diabetes Using a Thiazolidinedione or a Thiazolidinedione and Metformin

NCT00603239 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety of Semaglutide Once-weekly Versus Placebo as add-on to Basal Insulin Alone or Basal Insulin in Combination With Metformin in Subjects With Type 2 Diabetes

NCT02305381 ·Status: COMPLETED ·Phase: PHASE3

A Study to Evaluate the Glycemic Effects, Safety, and Tolerability of Exenatide Once Weekly in Subjects With Type 2 Diabetes Mellitus (DURATION-5)

NCT00877890 ·Status: COMPLETED ·Phase: PHASE3

A Phase 1, Single- and Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MEDI4166 in Subjects With Type 2 Diabetes

NCT02524782 ·Status: COMPLETED ·Phase: PHASE1

A Pilot Study Investigating Bioequivalence Between a Single Dose of Formulation 2 and Formulation 3 of MEDI0382

NCT03341013 ·Status: COMPLETED ·Phase: PHASE1

A Study to Test Whether Different Doses of BI 456906 Are Effective in Treating Adults With Type 2 Diabetes.

NCT04153929 ·Status: COMPLETED ·Phase: PHASE2

UBT251 Injection Phase II (Type 2 Diabetes Mellitus) Study

NCT07163624 ·Status: COMPLETED ·Phase: PHASE2

Multiple Ascending Dose Study of MK-5160 in Participants With Type 1 and Type 2 Diabetes Mellitus (MK-5160-002)

NCT03095651 ·Status: COMPLETED ·Phase: PHASE1

Effect of Retatrutide Compared With Semaglutide in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Metformin With or Without SGLT2 Inhibitor (TRANSCEND-T2D-2)

NCT06260722 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Safety and Efficacy of Biphasic Human Insulin Compared to EX1000 in Type 2 Diabetes

NCT00698802 ·Status: COMPLETED ·Phase: PHASE2

Study of Human Regular U-500 Insulin in Adult Participants With Type 2 Diabetes

NCT01774968 ·Status: COMPLETED ·Phase: PHASE4

Efficacy and Safety of Exenatide Once Weekly Suspension in Subjects With Type 2 Diabetes

NCT01652716 ·Status: COMPLETED ·Phase: PHASE3

An Exploratory Study of the Effect of Treatment Interruption on Safety of Exenatide in Patients With Type 2 Diabetes

NCT00516048 ·Status: COMPLETED ·Phase: PHASE3

Effects of Exenatide on Glycemic Control and Weight in Continuous Subcutaneous Insulin Infusion (CSII) Type 2 Treated Patients With Type 2 Diabetes

NCT01140893 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3

Transition From Basal/Bolus to Once-weekly Subcutaneous Semaglutide and Basal Insulin in Patients With T2D

NCT04538352 ·Status: COMPLETED ·Phase: PHASE4

The Efficacy of Insulin Degludec/Liraglutide in Controlling Glycaemia in Adults With Type 2 Diabetes Inadequately Controlled on GLP-1 Receptor Agonist and OAD Therapy

NCT01676116 ·Status: COMPLETED ·Phase: PHASE3

A Study Using Flash Glucose Measurements for a New Once-weekly Insulin (Insulin Icodec) in People With Type 2 Diabetes Who Have Not Used Insulin Before (ONWARDS 9)

NCT05823948 ·Status: COMPLETED ·Phase: PHASE3

GALLANT 4 Tesaglitazar vs. Glibenclamide

NCT00255541 ·Status: TERMINATED ·Phase: PHASE3

A Trial Comparing Insulin Degludec/Liraglutide, Insulin Degludec, and Liraglutide in Chinese Subjects With Type 2 Diabetes Inadequately Controlled on Oral Antidiabetic Drugs (OADs)

NCT03172494 ·Status: COMPLETED ·Phase: PHASE3

An Open Label, Multi-Center, Randomized, Parallel Group Study Comparing the Efficacy and Safety of Insulin VIAject™ and Regular Human Insulin in Patients With Type 2 Diabetes Mellitus

NCT00542633 ·Status: COMPLETED ·Phase: PHASE3

A Study of LY2608204 in Patients With Type 2 Diabetes

NCT01247363 ·Status: COMPLETED ·Phase: PHASE1

SUSTAIN SWITCH: A Research Study to Compare Two Dose Schedules of Semaglutide Taken Once Weekly in People With Type 2 Diabetes

NCT04287179 ·Status: WITHDRAWN ·Phase: PHASE3

Effect of Retatrutide Compared With Placebo in Participants With Type 2 Diabetes and Moderate or Severe Renal Impairment, With Inadequate Glycemic Control on Basal Insulin, With or Without Metformin and/or SGLT2 Inhibitor (TRANSCEND-T2D-3)

NCT06297603 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

A Multiple-Ascending Dose Study in Type 2 Diabetes Mellitus Patients

NCT01253278 ·Status: COMPLETED ·Phase: PHASE1